Revenue - Revenue Recognition (Details) - Revenue Benchmark	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Americas | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	45.00%	46.00%
Europe, Middle East, Africa | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	45.00%	44.00%
Asia Pacific | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10.00%	10.00%
High-Value Product Components | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	56.00%	52.00%
High-Value Product Delivery Devices | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	5.00%	5.00%
Standard Packaging | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	23.00%	24.00%
Contract-Manufactured Products | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	16.00%	19.00%
Biologics | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	43.00%	39.00%
Generics | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	17.00%	18.00%
Pharma | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	24.00%	24.00%
Contract-Manufactured Products | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	16.00%	19.00%